Clinical Trial Update: Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of cabazitaxel in previously treated patients with advanced or metastatic gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED